Loading…

Eli Lilly acquired a manufacturing facility in Pleasant Prairie, Wisconsin from Nexus Pharmaceuticals in 2024 and announced a $3 billion expansion to extend its global parenteral product manufacturing network. The expansion will add 750 jobs and bring total investment to $4 billion.
“Today’s announcement represents our single largest U.S. manufacturing investment outside our home state of Indiana and will add to our ability to expand capacity to make both our existing and future pipeline of medicines right here in the Midwest.”kaba.org
Summarized from public sources; check the original articles before acting on it.